NASDAQ: HCWBHcw Biologics Inc Stock Ownership - Who owns Hcw Biologics?
Insider buying vs selling
Have Hcw Biologics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Rick S. Greene | Director | 2024-02-20 | 35,714 | $1.40 | $50.00kBuy |
| Rebecca Byam | Chief Financial Officer | 2024-02-20 | 760,714 | $1.40 | $1.06MBuy |
| Hing C. Wong | Chief Executive Officer | 2024-02-20 | 739,288 | $1.40 | $1.04MBuy |
| Lee Flowers | SVP of Business Development | 2024-02-20 | 71,429 | $1.40 | $100.00kBuy |
| Scott T. Garrett | Director | 2024-02-20 | 142,858 | $1.40 | $200.00kBuy |
| Lisa M. Giles | Director | 2024-02-20 | 35,715 | $1.40 | $50.00kBuy |
| Peter Rhode | Officer | 2023-12-11 | 14,000 | $0.14 | $1.96kBuy |
| Lee Flowers | SVP of Business Development | 2023-12-08 | 7,501 | $0.14 | $1.05kBuy |
| Peter Rhode | Officer | 2023-11-17 | 15,000 | $0.14 | $2.10kBuy |
| Rebecca Byam | Chief Financial Officer | 2023-10-19 | 47,249 | $0.14 | $6.61kBuy |
HCWB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when HCWB insiders and whales buy or sell their stock.
HCWB Shareholders
What type of owners hold Hcw Biologics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Hing C. Wong | 42.45% | 16,054,156 | $25.53M | Insider |
| Rebecca Byam | 3.65% | 1,381,909 | $2.20M | Insider |
| Scott T. Garrett | 0.71% | 267,858 | $425.89k | Insider |
| Vanguard Group Inc | 0.54% | 205,142 | $326.18k | Institution |
| Lee Flowers | 0.50% | 190,238 | $302.48k | Insider |
| Hightower Advisors LLC | 0.48% | 179,810 | $285.90k | Institution |
| Avantax Planning Partners Inc | 0.47% | 179,541 | $285.47k | Institution |
| Geode Capital Management LLC | 0.36% | 134,436 | $213.75k | Institution |
| Cresset Asset Management LLC | 0.35% | 131,990 | $209.86k | Institution |
| Bridgeway Capital Management LLC | 0.22% | 84,700 | $134.67k | Institution |
HCWB vs Biotech Stocks
Hcw Biologics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.